CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Moonwalk raises $70M to test siRNA treatment for obesity

Positive
AI Analysis

Summary

Moonwalk Biosciences raised $70 million in funding to advance its siRNA-based obesity treatment candidate into clinical trials, reflecting a strategic shift toward genetic medicine approaches.

Importance:5/10
Sentiment:
0.60
fundingobesitysiRNAgenetic medicineclinical development
Related Companies

Read the original article

Published by Endpoints News on September 8, 2026 12:00 PM

Read Original